CONTACT

Thank you for visiting the AmideBio website.

If you would like to receive additional information on our products, discuss potential collaboration or joint development opportunities, please contact us at:

info@amidebio.com sales@amidebio.com
303 604 0296
331 South 104th Street Louisville, CO, 80027-9713

To receive periodic updates on our product development, subscribe to our Product News blog in the contact form on this page or connect to one of our social media pages.

COMPANY NEWS

AMIDEBIO Awarded $1.56M SBIR Phase II Grant to Further Development of its Novel Glucagons for the Treatment of Hyperinsulinism2019-09-30 - 07:33
AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $1.56M in funding through a Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The goal of this two-year grant is to enable an Investigational New Drug (IND) filing with the […]
David Brunel Takes Over Chairmanship at AmideBio2018-11-16 - 08:47
AmideBio LLC, a privately held biopharmaceutical company, announced today that David Brunel, a board member of AmideBio, has assumed the role of Chairman of the Board, replacing Misha Plam. Dr. Plam, a founder of AmideBio who retired recently as President and CEO, is now Chairman Emeritus. Read the full press release.
Diabetes Industry Veteran Pawel Fludzinski, Ph.D. assumed role of Company President of AmideBio2018-09-03 - 22:37
AmideBio LLC, a privately held biopharmaceutical company, announced today that Pawel Fludzinski, Ph.D. has assumed the role of Company President in addition to Chief Executive Officer, effective immediately. Dr. Misha Plam is retiring from the role but will remain Chairman of the Board of Directors. Read the full press release.

CONTACT

Send us an email